DCN had been reported to exert an inhibitory effect on cell migration in several types of nonglioma tumors 20, 21, 22, and was suggested to be involved in the inhibition of cell growth and proliferation in glioma partially through blunting TGF‐β signals both in vitro and in vivo23, 24. The gene discussed is DCN; the disease is central nervous system cancer.